Zhilong Huoxue Tongyu capsule inhibits rabbit model of hyperlipidemia and atherosclerosis through NF-κB/NLRP3 signaling pathway

Objective: Zhilong Huoxue Tongyu capsule (ZL) is a Chinese patent medicine for treating cardio-cerebral diseases. However, the pharmacological mechanism by which it regulates blood lipids and treats atherosclerosis (AS) is unclear. Therefore, the purpose of this study is to explore the mechanism of...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Mengnan Liu, Raoqiong Wang, Mingtai Chen, Zhongjing Hu, Mei Han, Maryam Mazhar, Jinyi Xue, Yuan Zou, Qibiao Wu, Sijin Yang
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2023-11-01
Reeks:	Heliyon
Onderwerpen:	Inflammation Pyroptosis Atherosclerosis Zhilong Huoxue Tongyu capsule Traditional Chinese medicine
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2405844023072341
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!